Home > Riviste > Minerva Cardiology and Angiology > Fascicoli precedenti > Minerva Cardiology and Angiology 2022 April;70(2) > Minerva Cardiology and Angiology 2022 April;70(2):273-84

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW  MYOCARDIAL AND PERICARDIAL DISEASE 

Minerva Cardiology and Angiology 2022 April;70(2):273-84

DOI: 10.23736/S2724-5683.21.05732-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Management of myocarditis in clinical practice

Anna BARITUSSIO 1, Andrea S. GIORDANI 1, Stefania RIZZO 2, Giulia MASIERO 1, Sabino ILICETO 1, Renzo MARCOLONGO 3, Alida L. CAFORIO 1

1 Unit of Cardiology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy; 2 Unit of Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University Hospital of Padua, University of Padua, Padua, Italy; 3 Unit of Hematology and Clinical Immunology, Department of Medicine, University Hospital of Padua, University of Padua, Padua, Italy



Myocarditis is an inflammatory heart muscle disease characterized by heterogeneous clinical presentation and outcome. Clinical heterogeneity of myocarditis, ranging from acute onset chest pain with electrocardiographic changes resembling an acute coronary syndrome, to arrhythmic storm and chronic decompensated heart failure, makes diagnosis challenging. However, a correct diagnosis is fundamental to proper patients’ management and should always be seeked. Although a definite diagnosis is only provided by endomyocardial biopsy, the European Society of Cardiology task force on myocardial and pericardial diseases provided specific criteria for the diagnosis of clinically suspected myocarditis, which has been facilitated by the advent of noninvasive imaging tests (i.e. cardiovascular magnetic resonance based myocardial tissue characterization). Due to the heterogeneous presentation and disease course of myocarditis, a tailored treatment would be the best strategy, but a standardized management is still not available. However, over the years, new, promising therapies, such as antiviral and immune-suppressive treatment, have come side by side to the standard pharmacological heart treatment, i.e. antiheart failure medications. In this paper we will review the basic principles of myocarditis management in clinical practice, including diagnostic work-up, conventional and disease-specific therapy and patients’ follow-up.


KEY WORDS: Myocarditis; Biopsy; Immunosuppression

inizio pagina